Daiichi Sankyo Company, Ltd (TSE: 4568) has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief ...

Tokyo: Daiichi Sankyo Company, Ltd has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief Executive ...

In order to ensure the solid achievement of FY2025 goals and to strengthen its management structure, Daiichi Sankyo’s Board ... for two years and other senior leadership roles in international ...

We will now would like to start Daiichi Sankyo's Financial Results Briefing ... years and have been responsible for the leadership and management of the team. As the Head of the R&D division ...

How does Daiichi Sankyo’s scientific specialism achieve success? Our success is rooted in our ability to adapt to the dynamic health environment, embrace innovative approaches and be laser ...

This pressing question brought together industry leaders, entrepreneurs, and investors at this year’s Frontiers Health conference in Berlin, where Daiichi Sankyo’s DSPACE team challenged ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.